Opening book details…
Can I read Renoprotection: One or many therapies? on EtoBox?
Renoprotection: One or many therapies? by Hebert, Lee A.; Wilmer, William A.; Falkenhain, Michael E.; Ladson-Wofford, Stephanie E.; Nahman, N. Stanley; Rovin, Brad H. is a Medicine article available to read on EtoBox.
What is Renoprotection: One or many therapies? about?
## Background: Renal disease that progresses to end-stage renal disease (esrd) imposes a great burden on the affected individual and on society, which mainly bears the cost of esrd (currently more than $10 billion to treat about 333,000 patients annually in the u.s.). thus, there is a great need to identify therapies that arrest the progression mechanisms common to all forms of renal disease. progress is being made. perhaps the most visible advance is the randomized controlled trials (rct) demonstrating the renoprotective effects of angiotensin-converting enzyme (ace) inhibitors. there are also numerous other promising renoprotective therapies. unfortunately, testing each therapy in rct is not feasible. thus the nephrologist has two choices: restrict renoprotective therapy to those shown to be effective in rct, or expand the use of renoprotective therapies to include those that, although unproven, are plausibly effective and prudent to use. the goal of this work is to provide the documentation needed for the nephrologist to choose between these strategies. ## Methods: This work first describes the mechanisms believed to be involved in the progression of renal disease. based largely
Who reads Renoprotection: One or many therapies??
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Hebert, Lee A.; Wilmer, William A.; Falkenhain, Michael E.; Ladson-Wofford, Stephanie E.; Nahman, N. Stanley; Rovin, Brad H.
- Publisher
- Nature Publishing Group; Elsevier ; Elsevier Inc.; Elsevier BV; ScienceOpen (ISSN 0085-2538)
- Published
- 2001
- Language
- EN
- Field
- Medicine (Health Sciences)